RAS Mutation
1 competing product in clinical development for RAS Mutation.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| OKI-179 + binimetinib | OnKure Therapeutics | Phase 1/2 | Completed | 33 |
1 competing product in clinical development for RAS Mutation.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| OKI-179 + binimetinib | OnKure Therapeutics | Phase 1/2 | Completed | 33 |